POLA Pharma Inc.

Japon


 
Quantité totale PI 77
Rang # Quantité totale PI 17 373
Note d'activité PI 0,4/5.0    1
Rang # Activité PI 933 755
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

32 0
3 0
40 2
0
 
Dernier brevet 2020 - Luliconazole as anti-acanthamoeb...
Premier brevet 2000 - Nitroimidazole derivative and di...
Dernière marque 2008 - RADIENCER
Première marque 2008 - RADIENCER

Industrie (Classification de Nice)

Derniers inventions, produits et services

2018 Invention Cancer stem cell inhibitor. To provide a novel medicine for suppressing cancer stem cells. An inh...
2017 Invention Foam, screen foamer composition, and evaluation method for same. Provided is a product exhibiting...
Invention Foam, screen foamer composition, and evaluation method for same. Provided is a product that is ab...
Invention Pharmaceutical composition for treatment of infection. The present invention addresses the proble...
Invention Amorphizing agent, amorphous composition comprising amorphizing agent and utilization thereof. Th...
2016 Invention Naphthoquinone compound and nuclear factor kappa-b (nf-κb) inhibitor comprising same as active in...
Invention Pharmaceutical composition for external use. A pharmaceutical composition for external use, incl...
Invention Anti-tritrichomonas agent. An object of the present invention is to provide a novel anti-Tritric...
Invention Anti-tritrichomonas agent. An object of the present invention is to provide a novel anti-Tritrich...
Invention Antifungal pharmaceutical composition. Disclosed is an antifungal agent for external use, which ...
Invention Luliconazole as anti-acanthamoeba agent and method for producing the same. An anti-Acanthamoeba ...
Invention Luliconazole as anti-acanthamoeba agent and method for producing the same. An object is to provid...
2015 Invention External composition for screen foamers. The present invention addresses the issue of providing a...
Invention Antigiardial agent. The present invention aims to provide an agent for the treatment of giardiasi...
Invention Pharmaceutical composition including anti-fungal agent and steroid. The present invention address...
Invention Process for producing composition of emulsion preparation type. preparing a composition, which f...
Invention Process for producing composition of emulsion preparation type. Provided is a technique for prepa...
Invention Method of evaluating pharmaceutical preparation containing luliconazole and index substance. Disc...
2014 Invention Pharmaceutical composition for treatment of pneumonia associated with fusarium fungus. The prese...
Invention Pharmaceutical composition for treatment of pneumonia associated with fusarium fungus. The presen...
Invention Antifungal composition. Disclosed is a pharmaceutical composition for antifungal use, comprising:...
Invention External-use composition producing foamed state upon use. Compositions having an increased amount...
Invention External-use composition producing foamed state upon use. Provided is a means for heightening the...
Invention Pharmaceutical composition for treating vaginitis or pneumonia. Provided is a pharmaceutical comp...
Invention Resin container filled with antifungal pharmaceutical composition. Provided is a means for stably...
Invention Crystal having specific crystal habit and pharmaceutical composition containing the crystal as ac...
2013 Invention Pharmaceutical composition for diseases caused by pathogenic microorganisms such as aspergillus. ...
Invention Pharmaceutical composition for diseases caused by pathogenic microorganisms such as candida. An ...
Invention Pharmaceutical composition for diseases caused by pathogenic microorganisms such as candida. An o...
Invention Crystal and pharmaceutical preparation containing the same crystal. An object is to provide means...
Invention Pharmaceutical composition containing luliconazole. Means for controlling the formation amount o...
Invention Pharmaceutical composition containing luliconazole. Means for controlling the formation amount of...
Invention Crystalline form having specific crystal habit and pharmaceutical composition containing this cry...
Invention Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of ...
Invention Amide derivative and use of the same as stability index of a luliconazole pharmaceutical formulat...
2012 Invention Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal. ...
2011 Invention Method of identifying abnormal cells by expression levels of etfb. Provided is a method for ident...
Invention Method of applying etfb to abnormal proliferation of cell, and abnormal proliferation inhibitor. ...
Invention Antimycotic pharmaceutical composition. 2 is halogen atom.)
2010 Invention Antimycotic pharmaceutical composition. In a pharmaceutical composition for external use containi...
2008 P/S Drugs for medical purposes; pharmaceutical preparations.